Robert Gurny
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Robert Gurny has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
E. Allémann
School of Pharmacy, University of Geneva, Geneva, Switzerland
3 shared publicationsEric Allémann
School of Pharmacy, University of Geneva, Quai Ernest-Ansermet 30, 1211, Geneva 4, Switzerland
3 shared publicationsEric Doelker
University of Geneva
3 shared publicationsGrégoire Schwach
3 shared publications- Michael Möller
School of Pharmaceutical Sciences, University of Geneva and University of Lausanne, Geneva 1221 , Switzerland
3 shared publications Béatrice Kaufmann
2 shared publications
Latest Publications
- 1 March 2015
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 481 (1-2) , 9-17
Controlled drug release from melt-extrudates through processing parameters: A chemometric approach
- 1 March 2015
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 481 (1-2) , 9-17
Controlled drug release from melt-extrudates through processing parameters: A chemometric approach
- 1 May 2013
- Published by Elsevier in Cardiovascular Pathology
- Vol. 22 (3) , e50-e51
Comparison of synthetic small-calibre biodegradable vs. stable ePTFE vascular prosthesis after long-term implantation in the rat aorta
- 1 May 2013
- Published by Elsevier in Cardiovascular Pathology
- Vol. 22 (3) , e50-e51
Comparison of synthetic small-calibre biodegradable vs. stable ePTFE vascular prosthesis after long-term implantation in the rat aorta
- 1 August 2012
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 81 (3) , 591-599
Single processing step toward injectable sustained-release formulations of Triptorelin based on a novel degradable semi-solid polymer
- 1 August 2012
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 81 (3) , 591-599
Single processing step toward injectable sustained-release formulations of Triptorelin based on a novel degradable semi-solid polymer
- 24 January 2011
- Published by Wiley in Photochemistry and Photobiology
- Vol. 87 (2) , 399-407
MPEG‐hexPLA Micelles as Novel Carriers for Hypericin, a Fluorescent Marker for Use in Cancer Diagnostics
Ovarian cancer is the most common gynecological cancer diagnosed in Western countries. Detection of micrometastases at an early stage of the disease could lead to a cure rate of 90% by limiting the spread of the disease outside the ovaries. In this article, hypericin (Hy), a hydrophobic photosensitizer used for the photodynamic diagnosis (PD) of ovarian cancer, was efficiently incorporated into a core of micelles made from methoxy-poly(ethylene glycol) and hexyl-substituted poly(lactides) copolymers. The fate of these micelles following intravenous injection was studied in vivo in two ovarian tumor-bearing animal models. In the chick embryo chorioallantoic membrane model, 17 times more Hy accumulated in tumor nodules when Hy was delivered with micelles than when Hy was delivered as an ethanol solution. Studies of the biodistribution of Hy in Fisher rats revealed escape of these nanosized micelles (<32 nm) from the mononuclear phagocyte system. Hy-loaded micelles showed maximal accumulation in tumors and demonstrated the best tumor/muscle contrast visible 3 h after injection in the rat model. The rapid and highly selective accumulation of Hy in tumors that we demonstrated in this study suggests that these micelle formulations could be used for the PD of ovarian cancer in the future.
- 24 January 2011
- Published by Wiley in Photochemistry and Photobiology
- Vol. 87 (2) , 399-407
MPEG‐hexPLA Micelles as Novel Carriers for Hypericin, a Fluorescent Marker for Use in Cancer Diagnostics
Ovarian cancer is the most common gynecological cancer diagnosed in Western countries. Detection of micrometastases at an early stage of the disease could lead to a cure rate of 90% by limiting the spread of the disease outside the ovaries. In this article, hypericin (Hy), a hydrophobic photosensitizer used for the photodynamic diagnosis (PD) of ovarian cancer, was efficiently incorporated into a core of micelles made from methoxy-poly(ethylene glycol) and hexyl-substituted poly(lactides) copolymers. The fate of these micelles following intravenous injection was studied in vivo in two ovarian tumor-bearing animal models. In the chick embryo chorioallantoic membrane model, 17 times more Hy accumulated in tumor nodules when Hy was delivered with micelles than when Hy was delivered as an ethanol solution. Studies of the biodistribution of Hy in Fisher rats revealed escape of these nanosized micelles (<32 nm) from the mononuclear phagocyte system. Hy-loaded micelles showed maximal accumulation in tumors and demonstrated the best tumor/muscle contrast visible 3 h after injection in the rat model. The rapid and highly selective accumulation of Hy in tumors that we demonstrated in this study suggests that these micelle formulations could be used for the PD of ovarian cancer in the future.
- 10 July 2009
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 17 (8) , 599-609
Toward the understanding of the photodynamic activity of m-THPP encapsulated in PLGA nanoparticles: correlation between nanoparticle properties and in vivo activity
Biodegradable polymeric nanoparticles (NP) are promising delivery systems for photosensitizers (PS). A hydrophobic PS, the meso-tetra(p-hydroxyphenyl)porphyrin (m-THPP) was encapsulated into NP made of poly(d,l-lactide-co-glycolide) using an emulsification-diffusion method, and poly(vinyl alcohol) (PVAL) as stabilizing agent during the emulsification step. Three batches of NP with mean diameters of 117, 285, and 593 nm, respectively, were prepared. NP of 117 nm exhibited the highest rate of reactive oxygen species production and the fastest m-THPP release determined by the transfer of m-THPP to serum proteins in vitro. Similarly, the 117 nm batch exhibited the highest in vivo photodynamic activity, as established in the chick embryo chorioallantoic membrane model. Our data suggest that m-THPP release before illumination is an important step for in vivo photodynamic activity especially for large NP. The NP size and the amount of residual PVAL at the NP surface were shown to control both the PS release and activity.
- 10 July 2009
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 17 (8) , 599-609
Toward the understanding of the photodynamic activity of m-THPP encapsulated in PLGA nanoparticles: correlation between nanoparticle properties and in vivo activity
Biodegradable polymeric nanoparticles (NP) are promising delivery systems for photosensitizers (PS). A hydrophobic PS, the meso-tetra(p-hydroxyphenyl)porphyrin (m-THPP) was encapsulated into NP made of poly(d,l-lactide-co-glycolide) using an emulsification-diffusion method, and poly(vinyl alcohol) (PVAL) as stabilizing agent during the emulsification step. Three batches of NP with mean diameters of 117, 285, and 593 nm, respectively, were prepared. NP of 117 nm exhibited the highest rate of reactive oxygen species production and the fastest m-THPP release determined by the transfer of m-THPP to serum proteins in vitro. Similarly, the 117 nm batch exhibited the highest in vivo photodynamic activity, as established in the chick embryo chorioallantoic membrane model. Our data suggest that m-THPP release before illumination is an important step for in vivo photodynamic activity especially for large NP. The NP size and the amount of residual PVAL at the NP surface were shown to control both the PS release and activity.
- 28 May 2008
- Published by Taylor & Francis
- p. 101-108
Bioadhesive Ophthalmic Drug Inserts (BODI) for Veterinary Use
- 28 May 2008
- Published by Taylor & Francis
- p. 101-108
Bioadhesive Ophthalmic Drug Inserts (BODI) for Veterinary Use
- 1 September 2007
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 67 (2) , 555-561
Biological conversion of a water-soluble prodrug of cyclosporine A
- 1 September 2007
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 67 (2) , 555-561
Biological conversion of a water-soluble prodrug of cyclosporine A
- 1 May 2007
- Published by American Society for Photobiology in Photochemistry and Photobiology
- Vol. 77 (6) , 638-644
Encapsulation of p-THPP into Nanoparticles: Cellular Uptake, Subcellular Localization and Effect of Serum on Photodynamic Activity¶
- 1 May 2007
- Published by American Society for Photobiology in Photochemistry and Photobiology
- Vol. 77 (6) , 638-644
Encapsulation of p-THPP into Nanoparticles: Cellular Uptake, Subcellular Localization and Effect of Serum on Photodynamic Activity¶
- 1 September 2006
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 7 (3) , E54-E60
Preparation of surfactant-free nanoparticles of methacrylic acid copolymers used for film coating
The aim of the present study was to prepare surfactant-free pseudolatexes of various methacrylic acid copolymers. These aqueous colloidal dispersions of polymeric materials for oral administration...
- 1 September 2006
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 7 (3) , E54-E60
Preparation of surfactant-free nanoparticles of methacrylic acid copolymers used for film coating
The aim of the present study was to prepare surfactant-free pseudolatexes of various methacrylic acid copolymers. These aqueous colloidal dispersions of polymeric materials for oral administration...